Skip to main
UNH
UNH logo

UnitedHealth Group (UNH) Stock Forecast & Price Target

UnitedHealth Group (UNH) Analyst Ratings

Based on 42 analyst ratings
Buy
Strong Buy 38%
Buy 48%
Hold 10%
Sell 5%
Strong Sell 0%

Bulls say

UnitedHealth Group’s strong position in the healthcare insurance sector is underscored by its anticipated 800,000 member growth in Medicare Advantage, translating to a 10% year-over-year enrollment increase, indicative of robust demand for its plans. The company has demonstrated effective cost controls with a shift towards HMO growth, which aligns with management's positive outlook on enrollment dynamics and margin improvements amidst a competitive landscape. Furthermore, the revised margin forecasts for OptumInsight, alongside expected EPS growth of 13-16% by 2026, suggest a potential for financial performance to revert to historical multiples, enhancing the overall investment thesis for UnitedHealth Group.

Bears say

UnitedHealth Group has experienced a sequential decline in Optum Health consumers, falling from 104 million to 100 million, raising concerns about its growth trajectory. Despite reporting a 4Q EPS of $6.81, which surpassed expectations, the company faced a significant MLR miss of 87.6% and a margin shortfall in OptumHealth, leading to a downward revision of its 2025 margin forecast by 20 basis points. The company's outlook is further challenged by anticipated pressures from cost trends in 2024, competitive government program dynamics, and various regulatory risks which could hinder profitability and market performance.

UnitedHealth Group (UNH) has been analyzed by 42 analysts, with a consensus rating of Buy. 38% of analysts recommend a Strong Buy, 48% recommend Buy, 10% suggest Holding, 5% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of UnitedHealth Group and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About UnitedHealth Group (UNH) Forecast

Analysts have given UnitedHealth Group (UNH) a Buy based on their latest research and market trends.

According to 42 analysts, UnitedHealth Group (UNH) has a Buy consensus rating as of Jul 5, 2025. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $392.07, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $392.07, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

UnitedHealth Group (UNH)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.